ArticleResearch square2026
TET1 Protects the Lungs from Diesel Exhaust Particle-Induced Inflammation and Abnormal Function.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Rationale: Diesel exhaust particles (DEP) are a major contributor to air pollution-associated asthma exacerbations, promoting oxidative stress, airway inflammation, and Th17-skewed immune responses. Although epigenetic mechanisms are increasingly recognized as key modulators of environmental lung disease, the role of the DNA demethylation enzyme TET1 in DEP-induced airway dysfunction remains poorly defined. We investigated the contribution of TET1 to epithelial and airway responses to DEP using complementary human and murine models. Methods: TET1 was silenced in human bronchial epithelial cells (HBECs) followed by DEP exposure, and transcriptomic alterations and cytokine production were assessed. In parallel, Tet1 heterozygous (Tet1 Results: Loss of TET1 markedly amplified DEP-induced transcriptional responses in HBECs, characterized by enhanced pro-inflammatory signaling and suppression of AhR-dependent xenobiotic detoxification genes. Conclusions: These findings suggest that epigenetic modulation of TET1-dependent pathways may represent a novel strategy to reduce susceptibility to pollution-induced airway disease. Collectively, our data identify TET1 as a central epigenetic regulator integrating detoxification and inflammatory programs in the airway epithelium during environmental exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.